Eli Lilly plans to expand its pipeline to address obesity-related conditions in India, says top executive
US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...
Xavier honors coach Tom Lilly as he nears retirement after 40 seasons
Xavier high school honored legendary girls' basketball coach Tom Lilly during Friday night's game, celebrating his remarkable ...
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
Eli Lilly started 2024 on a strong note but struggled during the second half of the year. The drugmaker dealt with several ...
extra17h
Brian McFadden is all smiles as he shares sweet snap with daughters
Brian McFadden has shared a sweet snap of him and two of his daughters, Molly and Lilly-Sue. Former Westlife member Brian was married to ex Kerry Katona for four years, with the pair sharing two ...
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
While Novo Nordisk's Ozempic is the most mainstream GLP-1 medication, Eli Lilly (NYSE: LLY) has two blockbuster weight loss ...
ARKG: Eyeing Favorable Macro 2025 Turns, Encouraging Momentum Trends
Financial writer recommends buying ARK Genomic Revolution ETF (ARKG) for potential growth in 2025. Explore more here.